sdbn.org

Plenty of ink has been devoted over the years about how San Diego’s biotech family tree can be traced back to Hybritech. The company was born in biotech’s halcyon days in the ’70s,...

[[Click headline to continue reading.]] More...

A few years ago, news articles in Business Week, Nature, and elsewhere described a veritable stampede among big pharmaceutical companies like Roche, Eli Lilly, Pfizer, and GlaxoSmithKline to work...

[[Click headline to continue reading.]] More...

Things were hopping over the past week in San Diego. Get into the rhythm here. —San Diego’s West Wireless Health Institute named Donald Casey chief executive officer. Casey was formerly...

[[Click headline to continue reading.]] More...

Acadia Pharmaceuticals of San Diego and its Canadian partner Biovail are continuing to move ahead with pimavanserin. The experimental drug, you might recall, failed last September in a trial testing...

[[Click headline to continue reading.]] More...

It’s pins-and-needles time for employees and investors at San Diego-based Amylin Pharmaceuticals and Waltham, MA-based Alkermes. The FDA has a deadline of Friday, March 12, to say whether it...

[[Click headline to continue reading.]] More...

San Diego’s West Wireless Health Institute today named Donald Casey as its first chief executive officer. Case, a former worldwide chairman of Johnson & Johnson’s Comprehensive Care...

[[Click headline to continue reading.]] More...

A wise man once said that overnight success in biotech takes about 15 years. All kidding aside, we at Xconomy recognize that real innovation in life sciences doesn’t just pop out of the blue on...

[[Click headline to continue reading.]] More...

Isis Pharmaceuticals (NASDAQ: ISIS), the Carlsbad, CA-based biotech company, said today it has earned a $6 million payment from Bristol-Myers Squibb for getting clearance from regulators to begin...

[[Click headline to continue reading.]] More...

Scientists in San Diego and Hayward, CA, have demonstrated the feasibility of using algae to produce commercial levels of human therapeutic proteins that are currently being used to treat emphysema...

[[Click headline to continue reading.]] More...

HIV has taught the pharmaceutical industry that the best way to fight an infectious virus that resists a single drug is to make a cocktail that attacks the virus in more than one way. Vertex...

[[Click headline to continue reading.]] More...